(Q44083576)

29 November 2017

title

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model (English)

1 reference

29 November 2017

8

Sastry KJ

2 references

ORCID Public Data File 2021

29 November 2017

1

Nehete PN

1 reference

29 November 2017

7

Arlinghaus RB

1 reference

29 November 2017

Chitta S

2

1 reference

29 November 2017

Hossain MM

3

1 reference

29 November 2017

Hill L

4

1 reference

29 November 2017

Bernacky BJ

5

1 reference

29 November 2017

Baze W

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

29 November 2017

1 reference

29 November 2017

volume

20

1 reference

29 November 2017

issue

5-6

1 reference

29 November 2017

page(s)

813-825

1 reference

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Modulation of primary human immunodeficiency virus type 1 envelope glycoprotein-mediated entry by human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Induction of human immunodeficiency virus-specific T cell responses in rhesus monkeys by synthetic peptides from gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Chimeric SHIV that causes CD4+ T cell loss and AIDS in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Differentiation of human dendritic cells from monocytes in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900408-X

7 January 2021

10.1016/S0264-410X(01)00408-X

Identifiers

DOI

1 reference

29 November 2017

1 reference